, Volume 38, Issue 4, pp 297–300 | Cite as

Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA

  • S. NaggieEmail author
  • J. Frederick
  • B. C. Pien
  • B. A. Miller
  • D. T. Provenzale
  • K. C. Goldberg
  • C. W. Woods
Brief Report



There is increasing recognition of the importance of community-associated Clostridium difficile infection (CA-CDI) despite little being known about its epidemiology.


We performed routine, active laboratory surveillance for CDI at the Durham Veterans Affairs Medical Center between January and December 2005 and extracted data from the electronic medical record for this investigation. Bivariable analyses were performed using the chi-square test, and continuous variables were compared using two sample t test and Wilcoxon rank sums.


We identified 108 CDI cases during the study period; 38 (35%) had onset of disease in the community and, of these, 31 (82%) met the definition for CA-CDI. A comparison of CA- versus healthcare facility-associated (HCFA)-CDI revealed that CA-CDI patients were younger (median age 58 vs. 69 years, respectively; p = 0.01), with the majority being <65 years, but had similar co-morbidities to HCFA-CDI patients. CA-CDI patients were reportedly exposed less frequently to an antimicrobial or a proton pump inhibitor than HCFA-CDI patients, while the latter showed a trend towards a higher 60-day all-cause mortality (3 vs. 17%, respectively; p = 0.06).


CA-CDI is the primary reason for community-onset CDI in our community. Compared to patients with HCFA-CDI, those with CA-CDI were younger, had fewer reported exposures to antimicrobials or PPIs, and had lower mortality. Further study is needed to identify unrecognized risk factors of CDI in the community.


CDI Clostridium difficile infection Colitis Community-associated Diarrhea 



We thank Drs. Clifford McDonald and Preeta Kutty for their advice and editing as well as continued collaboration and Dr. Kenneth Wilson for his continued mentorship and support. We would also like to thank Drs. McDonald and Dubberke at the SLVAMC for their collaboration on this project. This work was supported by an American College of Gastroenterology grant.

Conflict of interest statement

The authors have no conflict of interest to report.


  1. 1.
    Kazakova SV, Ware K, Baughman B, et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med. 2006;166:2518–24.CrossRefPubMedGoogle Scholar
  2. 2.
    McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Eng J Med. 2005;353:2433–41.CrossRefGoogle Scholar
  3. 3.
    Loo VG, Poirier L, Miller M, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–9.CrossRefPubMedGoogle Scholar
  4. 4.
    Dial S, Delaney JAC, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294:2989–95.CrossRefPubMedGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Surveillance for community-associated Clostridium difficile—Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57:340–3.Google Scholar
  6. 6.
    Kutty PK, Woods CW, Sena AC, et al. Risk factors for and estimated incidence of community-associated Clostridium difficile Infection, North Carolina, USA. Emerg Infect Dis. 2010;16:197–204.PubMedGoogle Scholar
  7. 7.
    Kutty PK, Benoit SR, Woods CW, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol. 2008;29:197–202.CrossRefPubMedGoogle Scholar
  8. 8.
    Chang HT, Krezolek D, Johnson S, et al. Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infect Control Hosp Epidemiol. 2007;28:926–31.CrossRefPubMedGoogle Scholar
  9. 9.
    Dubberke ER, McMullen KM, Mayfield JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30:332–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Price MF, Dao-Tran T, Garey KW, et al. Epidemiology and incidence of Clostridium difficile-associated diarrhea diagnosed upon admission to a university hospital. J Hosp Infect. 2007;65:42–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201–5.Google Scholar
  12. 12.
    Hirschhorn LR, Trnka Y, Onderdonk A, Lee MLT, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169:127–33.PubMedGoogle Scholar
  13. 13.
    Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis. 1995;20:S263–5.PubMedGoogle Scholar

Copyright information

© Urban & Vogel 2010

Authors and Affiliations

  • S. Naggie
    • 1
    • 2
    Email author
  • J. Frederick
    • 2
  • B. C. Pien
    • 1
  • B. A. Miller
    • 1
  • D. T. Provenzale
    • 2
    • 3
  • K. C. Goldberg
    • 2
  • C. W. Woods
    • 1
    • 2
  1. 1.Department of Internal Medicine, Division of Infectious DiseasesDuke University Medical CenterDurhamUSA
  2. 2.Durham Veterans Affairs Medical CenterDurhamUSA
  3. 3.Department of Internal Medicine, Division of GastroenterologyDuke University Medical CenterDurhamUSA

Personalised recommendations